Ipamorelin Dosing in Hepatic Impairment: A Clinical Guide Ipamorelin Dosing in Hepatic Impairment: What Prescribers Need to Know At a glance Drug / ipamorelin acetate (synthetic pentapeptide GH secretagogue) Standard dose range / 100 to 300 mcg subcutaneous, 1 to 3 times daily Hepatic-impairment starting dose / 100 mcg once daily (conservative) Mechanism / selective GHSR-1a agonist
In: Lawson LD, Bauer R, eds
Benefits of Renew Glutathione Soap
Hill RL, Singh IN, Brelsfoard J, Hall ED
A method of preventing dementia in a patient with Parkinson's disease or of improving or restoring cognitive function of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said cognitive function, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Its been studied extensively for conditions ranging from respiratory health to metabolic and mental well-being